Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,705 | 306 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,599 | 111 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $483.38 | 27 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $335.60 | 12 | $0 (2024) |
| Novo Nordisk Inc | $309.04 | 25 | $0 (2024) |
| Lilly USA, LLC | $255.04 | 17 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $166.03 | 9 | $0 (2024) |
| Antares Pharma, Inc. | $150.65 | 14 | $0 (2022) |
| Biohaven Pharmaceuticals, Inc. | $143.54 | 12 | $0 (2021) |
| Amarin Pharma Inc. | $126.87 | 8 | $0 (2021) |
| PFIZER INC. | $116.45 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,150 | 60 | ABBVIE INC. ($450.87) |
| 2023 | $1,048 | 66 | ABBVIE INC. ($455.23) |
| 2022 | $629.82 | 38 | ABBVIE INC. ($273.28) |
| 2021 | $1,878 | 142 | AbbVie Inc. ($419.84) |
All Payment Transactions
306 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/07/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.69 | General |
| Category: Diabetes | ||||||
| 11/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: Diabetes | ||||||
| 11/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: NEUROSCIENCE | ||||||
| 11/11/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $15.24 | General |
| 11/07/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $11.42 | General |
| Category: NEUROSCIENCE | ||||||
| 10/21/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: PSYCHIATRY | ||||||
| 10/14/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $15.63 | General |
| 10/07/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $5.57 | General |
| Category: NEUROSCIENCE | ||||||
| 09/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: NEUROSCIENCE | ||||||
| 09/20/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: Diabetes | ||||||
| 09/18/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: PSYCHIATRY | ||||||
| 09/12/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $8.59 | General |
| Category: NEUROSCIENCE | ||||||
| 09/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $30.16 | General |
| Category: NEUROSCIENCE | ||||||
| 09/05/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: NEUROSCIENCE | ||||||
| 08/23/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $26.75 | General |
| Category: NEUROSCIENCE | ||||||
| 08/16/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: Obesity | ||||||
| 08/14/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: PSYCHIATRY | ||||||
| 08/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: NEUROSCIENCE | ||||||
| 08/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.68 | General |
| Category: NEUROSCIENCE | ||||||
| 07/27/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: NEUROSCIENCE | ||||||
| 07/22/2024 | Organon Llc | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: ETONOGESTREL | ||||||
| 07/18/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $12.29 | General |
| Category: NEUROSCIENCE | ||||||
| 07/17/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 3 | 83 | 109 | $27,138 | $5,328 |
| 2021 | 7 | 266 | 420 | $85,392 | $18,322 |
| 2020 | 6 | 175 | 214 | $52,262 | $9,447 |
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 27 | 30 | $13,950 | $2,762 | 19.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 27 | 33 | $12,705 | $2,430 | 19.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 29 | 46 | $483.00 | $136.62 | 28.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 56 | 87 | $38,280 | $8,891 | 23.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 41 | 60 | $21,900 | $4,382 | 20.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 46 | 56 | $16,240 | $2,298 | 14.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 18 | 18 | $3,330 | $1,904 | 57.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 72 | 134 | $1,407 | $395.04 | 28.1% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 13 | 42 | $3,969 | $371.05 | 9.3% |
| 81002 | Urinalysis, manual test | Office | 2021 | 20 | 23 | $265.65 | $80.04 | 30.1% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 29 | 35 | $15,400 | $3,022 | 19.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 37 | 47 | $17,155 | $2,798 | 16.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 46 | 58 | $16,820 | $2,322 | 13.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 12 | 12 | $2,220 | $1,113 | 50.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 37 | 47 | $493.50 | $140.70 | 28.5% |
| 81002 | Urinalysis, manual test | Office | 2020 | 14 | 15 | $173.25 | $51.99 | 30.0% |
About Katlin Nadrchal, PA-C
Katlin Nadrchal, PA-C is a Family Medicine healthcare provider based in Papillion, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/12/2019. The National Provider Identifier (NPI) number assigned to this provider is 1689224529.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Katlin Nadrchal, PA-C has received a total of $4,705 in payments from pharmaceutical and medical device companies, with $1,150 received in 2024. These payments were reported across 306 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($4,705).
As a Medicare-enrolled provider, Nadrchal has provided services to 524 Medicare beneficiaries, totaling 743 services with total Medicare billing of $33,098. Data is available for 3 years (2020–2022), covering 16 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Physician Assistant
- Location Papillion, NE
- Active Since 09/12/2019
- Last Updated 08/18/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1689224529
Products in Payments
- VRAYLAR (Drug) $744.22
- REXULTI (Drug) $483.38
- UBRELVY (Drug) $480.39
- QULIPTA (Drug) $355.79
- Ozempic (Drug) $204.69
- NURTEC ODT (Drug) $199.18
- AIRSUPRA (Drug) $192.22
- Kerendia (Drug) $166.03
- Vascepa (Drug) $126.87
- XYOSTED (Drug) $116.11
- EMGALITY (Drug) $107.10
- NEXLETOL (Drug) $91.10
- XARELTO (Drug) $73.55
- TOSYMRA (Drug) $72.68
- MOUNJARO (Drug) $61.07
- Rybelsus (Drug) $60.04
- TRELEGY ELLIPTA (Drug) $57.04
- NEXPLANON (Drug) $54.27
- OPSUMIT (Drug) $47.90
- CAPLYTA (Drug) $46.70
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Papillion
Dr. Lorrie Mcgill, Md, MD
Family Medicine — Payments: $138,175
Dr. Jeffry Strohmyer, M.d, M.D
Family Medicine — Payments: $12,528
Sarah Hurd, M.d, M.D
Family Medicine — Payments: $8,818
Cindy Janssen, D.o, D.O
Family Medicine — Payments: $7,960
Adam Rasmussen, Md, MD
Family Medicine — Payments: $3,774
Paul Mueller, M.d, M.D
Family Medicine — Payments: $2,838